Unknown NA INTERVENTIONAL 2-arm NCT00162435

Genetic Determinants of Warfarin Anticoagulation Effect

Warfarin Induction Regimen Based Upon CYP2C9, VKORC1 Factor VII Genotyping, PMR and INR Monitoring, as Compared to the Conventional Regimen: a Prospective Controlled Study

Sponsor: Hadassah Medical Organization

Conditions Atrial Fibrillation Pulmonary Embolism Venous Thrombosis

Interventions Warfarin

Updated 7 times since 2017 Last updated: Jun 11, 2018 Started: Aug 31, 2002 Primary completion: Dec 31, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Atrial Fibrillation and Pulmonary Embolism and is currently ongoing. Hadassah Medical Organization leads this study, which shows 7 recorded versions since 2002 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jul 2018 — Jan 2021 [monthly]

Recruiting NA
Jun 2018 — Jul 2018 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Mar 2017 — Jun 2018 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Jan 2017 — Mar 2017 [monthly]

Unknown Status NA

First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hadassah Medical Organization
Israel Science Foundation
Ministry of Health, Israel
United States - Israel Binational Science Foundation

Data source: Hadassah Medical Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel